Eli Lilly and (LLY) PE Ratio: History & Chart

Eli Lilly and Company(LLY)

Drug Manufacturers - General · Indianapolis, IN

$1,115.25-7.75 (-0.69%)

Delayed quote: Sep 11, 2026, 3:59 PM EDT

About Eli Lilly and Company

Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500). Furthermore, Eli Lilly provides specialized treatments for type 2 diabetes, such as Jardiance, Trajenta, and Trulicity. In oncology, Eli Lilly offers a robust portfolio targeting various cancers. These include Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza, indicated for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal and various head and neck cancers; Retevmo, used in metastatic NSCLC, medullary thyroid, and other thyroid cancers; Tyvyt for relapsed or refractory classic Hodgkin's lymphoma and non-squamous NSCLC; and Verzenio, prescribed for HR+, HER2- metastatic breast cancer, node-positive, and early breast cancer. For autoimmune and inflammatory conditions, the company markets Olumiant for rheumatoid arthritis, and Taltz, which addresses plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Addressing neurological and pain management needs, Eli Lilly provides Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain. Emgality is available for migraine prevention and episodic cluster headaches, while Zyprexa treats schizophrenia, bipolar I disorder, and aids in bipolar maintenance. Other significant products include Bamlanivimab and etesevimab, along with Bebtelovimab, both developed for COVID-19. Cialis is offered for erectile dysfunction and benign prostatic hyperplasia, and Forteo is available for osteoporosis. Eli Lilly actively engages in strategic collaborations with numerous partners, including Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Established in 1876, Eli Lilly and Company maintains its corporate headquarters in Indianapolis, Indiana.

Indianapolis, IN

50,000 employees

www.lilly.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: David A. Ricks

View full financials

LLY PE Ratio Metrics

PE RATIO

37.42

PE RATIO AVG TTM

44.99

PE RATIO AVG 3Y

79.96

PE RATIO AVG 5Y

68.61

PE RATIO AVG 10Y

48.74

PE RATIO AVG 15Y

35.61

PE RATIO AVG 20Y

30.67

CURRENT VS TTM AVG

-16.83%

CURRENT VS 3Y AVG

-53.20%

CURRENT VS 5Y AVG

-45.46%

CURRENT VS 10Y AVG

-23.23%

CURRENT VS 15Y AVG

+5.09%

CURRENT VS 20Y AVG

+22.01%

SECTOR MEDIAN · HEALTHCARE

27.27

median of 75 covered companies

CURRENT VS SECTOR MEDIAN

+37.22%

vs the sector median at left

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Eli Lilly and Company (LLY)	$1.05T	37.42	44.99	79.96	68.61
Johnson & Johnson (JNJ)vs ›	$640.02B	30.77	23.66	19.46	21.98
AbbVie Inc. (ABBV)vs ›	$454.17B	72.43	119.42	81.10	58.87
Merck & Co., Inc. (MRK)vs ›	$355.49B	115.15	28.88	95.90	67.06
UnitedHealth Group Incorporated (UNH)vs ›	$344.27B	24.38	22.05	25.06	25.46
Roche Holding AG (RHHBY)vs ›	$336.71B	N/A	N/A	N/A	N/A
AstraZeneca PLC (AZN)vs ›	$248.40B	24.05	28.96	33.90	64.77
Thermo Fisher Scientific Inc. (TMO)vs ›	$226.62B	32.80	30.21	32.10	31.41
Amgen Inc. (AMGN)vs ›	$203.66B	23.45	25.13	30.40	26.59
Novo Nordisk A/S (NVO)vs ›	$191.26B	10.61	12.79	27.72	31.12

NAME

MARKET CAP

PE RATIO

TTM

Eli Lilly and Company (LLY)

$1.05T

37.42

44.99

79.96

68.61

Johnson & Johnson (JNJ)vs ›

$640.02B

30.77

23.66

19.46

21.98

AbbVie Inc. (ABBV)vs ›

$454.17B

72.43

119.42

81.10

58.87

Merck & Co., Inc. (MRK)vs ›

$355.49B

115.15

28.88

95.90

67.06

UnitedHealth Group Incorporated (UNH)vs ›

$344.27B

24.38

22.05

25.06

25.46

Roche Holding AG (RHHBY)vs ›

$336.71B

N/A

AstraZeneca PLC (AZN)vs ›

$248.40B

24.05

28.96

33.90

64.77

Thermo Fisher Scientific Inc. (TMO)vs ›

$226.62B

32.80

30.21

32.10

31.41

Amgen Inc. (AMGN)vs ›

$203.66B

23.45

25.13

30.40

26.59

Novo Nordisk A/S (NVO)vs ›

$191.26B

10.61

12.79

27.72

31.12

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

PE Ratio FAQ

What is the P/E ratio for Eli Lilly and Company (LLY)?

The P/E ratio for LLY stock is 37.42.

Is Eli Lilly and Company's P/E ratio high or low?

The P/E ratio of 37.42 is 45% below its 5-year average of 68.61, near the low end of its 5-year range (33.69–148.69).

What is the TTM average P/E ratio for Eli Lilly and Company (LLY)?

The TTM average P/E ratio for LLY stock is 44.99.

What is the 3Y average P/E ratio for Eli Lilly and Company (LLY)?

The 3Y average P/E ratio for LLY stock is 79.96.

What is the 5Y average P/E ratio for Eli Lilly and Company (LLY)?

The 5Y average P/E ratio for LLY stock is 68.61.

What is the 10Y average P/E ratio for Eli Lilly and Company (LLY)?

The 10Y average P/E ratio for LLY stock is 48.74.

What is the 15Y average P/E ratio for Eli Lilly and Company (LLY)?

The 15Y average P/E ratio for LLY stock is 35.61.

What is the 20Y average P/E ratio for Eli Lilly and Company (LLY)?

The 20Y average P/E ratio for LLY stock is 30.67.

DATE	PE RATIO
2026-09-10	37.69
2026-09-09	37.73
2026-09-08	37.72
2026-09-04	38.57
2026-09-03	38.91
2026-09-02	38.93
2026-09-01	38.93
2026-08-31	38.82
2026-08-28	39.42
2026-08-27	39.47
2026-08-26	39.91
2026-08-25	41.40
2026-08-24	41.84
2026-08-21	42.13
2026-08-20	41.76
2026-08-19	42.96
2026-08-18	41.13
2026-08-17	39.70
2026-08-14	39.60
2026-08-13	40.57
2026-08-12	40.95
2026-08-11	40.77
2026-08-10	41.34
2026-08-07	39.79
2026-08-06	40.00
2026-08-05	41.56
2026-08-04	39.63
2026-08-03	39.84
2026-07-31	40.81
2026-07-30	41.03
2026-07-29	42.98
2026-07-28	43.36
2026-07-27	42.54
2026-07-24	42.49
2026-07-23	42.13
2026-07-22	41.31
2026-07-21	41.76
2026-07-20	40.74
2026-07-17	41.89
2026-07-16	41.53
2026-07-15	41.09
2026-07-14	40.94
2026-07-13	41.98
2026-07-10	42.22
2026-07-09	43.23
2026-07-08	43.19
2026-07-07	43.89
2026-07-06	42.63
2026-07-02	43.12
2026-07-01	42.34
2026-06-30	42.61
2026-06-29	43.69
2026-06-26	42.92
2026-06-25	40.06
2026-06-24	39.69
2026-06-23	39.33
2026-06-22	39.15
2026-06-18	39.03
2026-06-17	39.50
2026-06-16	39.88
2026-06-15	40.12
2026-06-12	40.25
2026-06-11	41.24
2026-06-10	40.37
2026-06-09	40.66
2026-06-08	40.82
2026-06-05	40.19
2026-06-04	39.97
2026-06-03	38.32
2026-06-02	37.80
2026-06-01	38.44
2026-05-29	39.25
2026-05-28	40.03
2026-05-27	38.47
2026-05-26	37.82
2026-05-22	37.83
2026-05-21	37.00
2026-05-20	36.19
2026-05-19	36.28
2026-05-18	35.10
2026-05-15	35.70
2026-05-14	35.76
2026-05-13	36.08
2026-05-12	35.16
2026-05-11	34.35
2026-05-08	33.69
2026-05-07	34.63
2026-05-06	35.06
2026-05-05	35.13
2026-05-04	34.38
2026-05-01	34.22
2026-04-30	40.72
2026-04-29	37.09
2026-04-28	38.08
2026-04-27	37.83
2026-04-24	38.52
2026-04-23	39.98
2026-04-22	40.15
2026-04-21	39.35
2026-04-20	40.08
2026-04-17	40.39
2026-04-16	39.39
2026-04-15	39.43
2026-04-14	40.20
2026-04-13	40.50
2026-04-10	40.94
2026-04-09	41.62
2026-04-08	41.54
2026-04-07	40.57
2026-04-06	40.39
2026-04-02	40.77
2026-04-01	41.59
2026-03-31	40.08
2026-03-30	38.63
2026-03-27	38.27
2026-03-26	39.08
2026-03-25	39.93
2026-03-24	39.35
2026-03-23	39.68
2026-03-20	39.51
2026-03-19	39.98
2026-03-18	40.00
2026-03-17	40.54
2026-03-16	43.10
2026-03-13	42.92
2026-03-12	42.58
2026-03-11	43.57
2026-03-10	43.63
2026-03-09	43.94
2026-03-06	43.15
2026-03-05	42.84
2026-03-04	43.73
2026-03-03	43.91
2026-03-02	44.36
2026-02-27	45.84
2026-02-26	44.53
2026-02-25	44.83
2026-02-24	45.41
2026-02-23	46.12
2026-02-20	43.99
2026-02-19	44.58
2026-02-18	44.47
2026-02-17	45.14
2026-02-13	45.32
2026-02-12	50.80
2026-02-11	49.67
2026-02-10	50.13
2026-02-09	51.11
2026-02-06	51.77
2026-02-05	49.94
2026-02-04	54.16
2026-02-03	49.09
2026-02-02	51.08
2026-01-30	50.74
2026-01-29	50.10
2026-01-28	50.09
2026-01-27	50.86
2026-01-26	51.99
2026-01-23	52.07
2026-01-22	53.20
2026-01-21	52.77
2026-01-20	50.94
2026-01-16	50.80
2026-01-15	50.54
2026-01-14	52.51
2026-01-13	52.70
2026-01-12	52.89
2026-01-09	52.03
2026-01-08	53.09
2026-01-07	54.21
2026-01-06	52.06
2026-01-05	50.95
2026-01-02	52.86
2025-12-31	52.58
2025-12-30	52.83
2025-12-29	52.81
2025-12-26	52.73
2025-12-24	52.69
2025-12-23	52.43
2025-12-22	52.67
2025-12-19	52.42
2025-12-18	51.71
2025-12-17	50.97
2025-12-16	51.58
2025-12-15	51.97
2025-12-12	50.27
2025-12-11	49.38
2025-12-10	48.61
2025-12-09	48.05
2025-12-08	48.81
2025-12-05	49.43
2025-12-04	49.63
2025-12-03	50.57
2025-12-02	51.18
2025-12-01	51.76
2025-11-28	52.62
2025-11-26	54.03
2025-11-25	54.30
2025-11-24	52.36
2025-11-21	51.84
2025-11-20	51.04
2025-11-19	51.35
2025-11-18	50.39
2025-11-17	49.99
2025-11-14	50.16
2025-11-13	50.04
2025-11-12	49.79
2025-11-11	48.37
2025-11-10	47.29
2025-11-07	45.22
2025-11-06	45.86
2025-11-05	45.29
2025-11-04	44.37
2025-11-03	43.86
2025-10-31	42.21
2025-10-30	55.20
2025-10-29	53.17
2025-10-28	53.60
2025-10-27	54.01
2025-10-24	53.95
2025-10-23	53.66
2025-10-22	53.10
2025-10-21	52.26
2025-10-20	52.87
2025-10-17	52.47
2025-10-16	53.55
2025-10-15	54.02
2025-10-14	53.09
2025-10-13	53.56
2025-10-10	54.48
2025-10-09	55.91
2025-10-08	55.28
2025-10-07	55.14
2025-10-06	55.23
2025-10-03	54.89
2025-10-02	53.58
2025-10-01	53.95
2025-09-30	49.87
2025-09-29	47.48
2025-09-26	47.36
2025-09-25	46.71
2025-09-24	48.49
2025-09-23	48.82
2025-09-22	49.34
2025-09-19	49.15
2025-09-18	49.86
2025-09-17	49.68
2025-09-16	49.98
2025-09-15	48.90
2025-09-12	49.37
2025-09-11	49.43
2025-09-10	49.32
2025-09-09	49.06
2025-09-08	48.28
2025-09-05	47.53
2025-09-04	48.56
2025-09-03	48.22
2025-09-02	48.05
2025-08-29	47.88
2025-08-28	47.84

DATE

PE RATIO

2026-09-10

37.69

2026-09-09

37.73

2026-09-08

37.72

2026-09-04

38.57

2026-09-03

38.91

2026-09-02

38.93

2026-09-01

38.93

2026-08-31

38.82

2026-08-28

39.42

2026-08-27

39.47

2026-08-26

39.91

2026-08-25

41.40

2026-08-24

41.84

2026-08-21

42.13

2026-08-20

41.76

2026-08-19

42.96

2026-08-18

41.13

2026-08-17

39.70

2026-08-14

39.60

2026-08-13

40.57

2026-08-12

40.95

2026-08-11

40.77

2026-08-10

41.34

2026-08-07

39.79

2026-08-06

40.00

2026-08-05

41.56

2026-08-04

39.63

2026-08-03

39.84

2026-07-31

40.81

2026-07-30

41.03

2026-07-29

42.98

2026-07-28

43.36

2026-07-27

42.54

2026-07-24

42.49

2026-07-23

42.13

2026-07-22

41.31

2026-07-21

41.76

2026-07-20

40.74

2026-07-17

41.89

2026-07-16

41.53

2026-07-15

41.09

2026-07-14

40.94

2026-07-13

41.98

2026-07-10

42.22

2026-07-09

43.23

2026-07-08

43.19

2026-07-07

43.89

2026-07-06

42.63

2026-07-02

43.12

2026-07-01

42.34

2026-06-30

42.61

2026-06-29

43.69

2026-06-26

42.92

2026-06-25

40.06

2026-06-24

39.69

2026-06-23

39.33

2026-06-22

39.15

2026-06-18

39.03

2026-06-17

39.50

2026-06-16

39.88

2026-06-15

40.12

2026-06-12

40.25

2026-06-11

41.24

2026-06-10

40.37

2026-06-09

40.66

2026-06-08

40.82

2026-06-05

40.19

2026-06-04

39.97

2026-06-03

38.32

2026-06-02

37.80

2026-06-01

38.44

2026-05-29

39.25

2026-05-28

40.03

2026-05-27

38.47

2026-05-26

37.82

2026-05-22

37.83

2026-05-21

37.00

2026-05-20

36.19

2026-05-19

36.28

2026-05-18

35.10

2026-05-15

35.70

2026-05-14

35.76

2026-05-13

36.08

2026-05-12

35.16

2026-05-11

34.35

2026-05-08

33.69

2026-05-07

34.63

2026-05-06

35.06

2026-05-05

35.13

2026-05-04

34.38

2026-05-01

34.22

2026-04-30

40.72

2026-04-29

37.09

2026-04-28

38.08

2026-04-27

37.83

2026-04-24

38.52

2026-04-23

39.98

2026-04-22

40.15

2026-04-21

39.35

2026-04-20

40.08

2026-04-17

40.39

2026-04-16

39.39

2026-04-15

39.43

2026-04-14

40.20

2026-04-13

40.50

2026-04-10

40.94

2026-04-09

41.62

2026-04-08

41.54

2026-04-07

40.57

2026-04-06

40.39

2026-04-02

40.77

2026-04-01

41.59

2026-03-31

40.08

2026-03-30

38.63

2026-03-27

38.27

2026-03-26

39.08

2026-03-25

39.93

2026-03-24

39.35

2026-03-23

39.68

2026-03-20

39.51

2026-03-19

39.98

2026-03-18

40.00

2026-03-17

40.54

2026-03-16

43.10

2026-03-13

42.92

2026-03-12

42.58

2026-03-11

43.57

2026-03-10

43.63

2026-03-09

43.94

2026-03-06

43.15

2026-03-05

42.84

2026-03-04

43.73

2026-03-03

43.91

2026-03-02

44.36

2026-02-27

45.84

2026-02-26

44.53

2026-02-25

44.83

2026-02-24

45.41

2026-02-23

46.12

2026-02-20

43.99

2026-02-19

44.58

2026-02-18

44.47

2026-02-17

45.14

2026-02-13

45.32

2026-02-12

50.80

2026-02-11

49.67

2026-02-10

50.13

2026-02-09

51.11

2026-02-06

51.77

2026-02-05

49.94

2026-02-04

54.16

2026-02-03

49.09

2026-02-02

51.08

2026-01-30

50.74

2026-01-29

50.10

2026-01-28

50.09

2026-01-27

50.86

2026-01-26

51.99

2026-01-23

52.07

2026-01-22

53.20

2026-01-21

52.77

2026-01-20

50.94

2026-01-16

50.80

2026-01-15

50.54

2026-01-14

52.51

2026-01-13

52.70

2026-01-12

52.89

2026-01-09

52.03

2026-01-08

53.09

2026-01-07

54.21

2026-01-06

52.06

2026-01-05

50.95

2026-01-02

52.86

2025-12-31

52.58

2025-12-30

52.83

2025-12-29

52.81

2025-12-26

52.73

2025-12-24

52.69

2025-12-23

52.43

2025-12-22

52.67

2025-12-19

52.42

2025-12-18

51.71

2025-12-17

50.97

2025-12-16

51.58

2025-12-15

51.97

2025-12-12

50.27

2025-12-11

49.38

2025-12-10

48.61

2025-12-09

48.05

2025-12-08

48.81

2025-12-05

49.43

2025-12-04

49.63

2025-12-03

50.57

2025-12-02

51.18

2025-12-01

51.76

2025-11-28

52.62

2025-11-26

54.03

2025-11-25

54.30

2025-11-24

52.36

2025-11-21

51.84

2025-11-20

51.04

2025-11-19

51.35

2025-11-18

50.39

2025-11-17

49.99

2025-11-14

50.16

2025-11-13

50.04

2025-11-12

49.79

2025-11-11

48.37

2025-11-10

47.29

2025-11-07

45.22

2025-11-06

45.86

2025-11-05

45.29

2025-11-04

44.37

2025-11-03

43.86

2025-10-31

42.21

2025-10-30

55.20

2025-10-29

53.17

2025-10-28

53.60

2025-10-27

54.01

2025-10-24

53.95

2025-10-23

53.66

2025-10-22

53.10

2025-10-21

52.26

2025-10-20

52.87

2025-10-17

52.47

2025-10-16

53.55

2025-10-15

54.02

2025-10-14

53.09

2025-10-13

53.56

2025-10-10

54.48

2025-10-09

55.91

2025-10-08

55.28

2025-10-07

55.14

2025-10-06

55.23

2025-10-03

54.89

2025-10-02

53.58

2025-10-01

53.95

2025-09-30

49.87

2025-09-29

47.48

2025-09-26

47.36

2025-09-25

46.71

2025-09-24

48.49

2025-09-23

48.82

2025-09-22

49.34

2025-09-19

49.15

2025-09-18

49.86

2025-09-17

49.68

2025-09-16

49.98

2025-09-15

48.90

2025-09-12

49.37

2025-09-11

49.43

2025-09-10

49.32

2025-09-09

49.06

2025-09-08

48.28

2025-09-05

47.53

2025-09-04

48.56

2025-09-03

48.22

2025-09-02

48.05

2025-08-29

47.88

2025-08-28

47.84

PE Ratio: 37.42

LLY PE Ratio Chart

LLY Average PE Ratio Chart

LLY Current vs Average PE Ratio Chart

LLY PE Ratio Metrics

LLY Competitors' PE Ratio

P/E vs. its own history

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

PE Ratio FAQ

LLY PE Ratio History

Related Metrics